Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +520 | +4.98% | $0.00 | 11K | Sep 1, 2023 | Direct | F1, F2 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$71K | -180 | -1.64% | $394.60 | 10.8K | Sep 1, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +329 | +3.05% | $0.00 | 11.1K | Sep 1, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$45K | -114 | -1.03% | $394.60 | 11K | Sep 1, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +361 | +3.28% | $0.00 | 11.4K | Sep 2, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$49.3K | -125 | -1.1% | $394.60 | 11.2K | Sep 2, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +495 | +4.41% | $0.00 | 11.7K | Sep 3, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$67.9K | -172 | -1.47% | $394.60 | 11.6K | Sep 3, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +600 | +5.19% | $0.00 | 12.2K | Sep 4, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$109K | -275 | -2.26% | $394.60 | 11.9K | Sep 4, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -520 | -24.98% | $0.00 | 1.56K | Sep 1, 2023 | Bio-Rad A Common Stock | 520 | $0.00 | Direct | F3, F4 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -329 | -33.3% | $0.00 | 659 | Sep 1, 2023 | Bio-Rad A Common Stock | 329 | $0.00 | Direct | F3, F5 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -361 | -50% | $0.00 | 361 | Sep 2, 2023 | Bio-Rad A Common Stock | 361 | $0.00 | Direct | F3, F6 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -495 | -50% | $0.00 | 495 | Sep 3, 2023 | Bio-Rad A Common Stock | 495 | $0.00 | Direct | F3, F7 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -600 | -100% | $0.00* | 0 | Sep 4, 2023 | Bio-Rad A Common Stock | 600 | $0.00 | Direct | F3, F8 |
Id | Content |
---|---|
F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
F2 | Includes 31.8970 and 24.7960 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2023 and 06/30/2023. |
F3 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
F4 | On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F5 | On September 1, 2021, the reporting person was granted 1,317 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F6 | On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F7 | On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |
F8 | On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |